Comparison between Serum Levels of Ca15-3 (U/ml) and CEA (ng/mL), Ca19-9 (U/ml) and CEA (ng/ml) and TSPA (U/ml) in Control, Breast, Colorectal and Prostate Cancer Patients. The gene discussed is CEACAM5; the disease is prostate carcinoma.